Stock Taper 
ADAR1 CAPITAL MANAGEMENT, LLC
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Relmada Therapeutics, Inc. | RLMD | 451.92K | $3.13M |
 Cytokinetics, Incorporated | CYTK | 457.91K | $39.01M |
 Amylyx Pharmaceuticals, Inc. | AMLX | 494.38K | $8.88M |
 Biohaven Ltd. | BHVN | 501.69K | $7.47M |
 Korro Bio, Inc. | KRRO | 540.05K | $7.12M |
 Viking Therapeutics, Inc. | VKTX | 574.04K | $22.39M |
 ARS Pharmaceuticals, Inc. | SPRY | 601K | $4.81M |
 Celldex Therapeutics, Inc. | CLDX | 619.54K | $23.05M |
 Eledon Pharmaceuticals, Inc. | ELDN | 647.81K | $2.55M |
 Replimune Group, Inc. | REPL | 655.78K | $7.26M |
 Sarepta Therapeutics, Inc. | SRPT | 730.65K | $13.13M |
 Lexicon Pharmaceuticals, Inc. | LXRX | 750K | $1.8M |
 Atai Beckley Inc. | ATAI | 913.24K | $4.81M |
 Protara Therapeutics, Inc. | TARA | 940.51K | $3.59M |
 Septerna Inc | SEPN | 940.75K | $31.51M |
 Protagonist Therapeutics, Inc. | PTGX | 960.86K | $117.78M |
 Denali Therapeutics Inc. | DNLI | 1.03M | $26.47M |
 Crinetics Pharmaceuticals, Inc. | CRNX | 1.22M | $45.73M |
 Arbutus Biopharma Corp | ABUS | 1.27M | $6.09M |
 Agios Pharmaceuticals, Inc. | AGIO | 1.29M | $47.8M |